2,550 Shares in Mettler-Toledo International, Inc. $MTD Acquired by Weitz Investment Management Inc.

Weitz Investment Management Inc. bought a new stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,550 shares of the medical instruments supplier’s stock, valued at approximately $3,258,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. XXEC Inc. purchased a new position in shares of Mettler-Toledo International during the 2nd quarter worth $77,044,000. BlackRock Inc. bought a new position in Mettler-Toledo International in the 2nd quarter worth $2,404,713,000. Capital International Investors raised its holdings in Mettler-Toledo International by 12.7% in the 4th quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after purchasing an additional 109,508 shares during the period. T. Rowe Price Investment Management Inc. lifted its position in Mettler-Toledo International by 0.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock valued at $964,174,000 after purchasing an additional 3,157 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in Mettler-Toledo International by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock valued at $830,879,000 after purchasing an additional 14,106 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 2,240 shares of the stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $1,432.00, for a total value of $3,207,680.00. Following the sale, the chief financial officer directly owned 5,579 shares of the company’s stock, valued at $7,989,128. This represents a 28.65% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gerry Keller sold 240 shares of the company’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total value of $342,513.60. Following the transaction, the insider directly owned 259 shares in the company, valued at approximately $369,629.26. This represents a 48.10% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 3,312 shares of company stock worth $4,750,362. Insiders own 0.71% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of Mettler-Toledo International stock opened at $1,393.43 on Friday. The stock has a market cap of $27.92 billion, a price-to-earnings ratio of 31.36, a price-to-earnings-growth ratio of 2.87 and a beta of 1.23. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. The stock has a 50 day moving average price of $1,319.66 and a 200-day moving average price of $1,274.32. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, beating the consensus estimate of $10.78 by $0.68. The company had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.Mettler-Toledo International’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $10.09 EPS. Equities analysts expect that Mettler-Toledo International, Inc. will post 47.35 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Wells Fargo & Company lifted their price objective on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. decreased their target price on shares of Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Citigroup lowered their price target on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Stifel Nicolaus upped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. Finally, Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, August 4th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $1,461.27.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.